| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |